Jens J. Holst

Novo Nordisk Foundation (DK)

Research Areas

Discover Papers by Jens J. Holst

Access 250+ million papers and cite this researcher's work with AI assistance

Try AnswerThis Free →

H-index

192

Publications

2699

Citations

157627

i10-index

1578

Publications & Citations Over Time

Top Cited Publications

Want to find and read papers by this researcher? AnswerThis gives you instant access.

Title	Year	Citations
The Physiology of Glucagon-like Peptide 1	2007	3107
Type 2 diabetes mellitus	2015	2351
Preserved incretin activity of glucagon-like pepti...	1993	1609
Glucagon-like peptide 1 (GLP-1)	2019	1549
Glucagon-like peptide 1 promotes satiety and suppr...	1998	1372
Effect of 6-week course of glucagon-like peptide 1...	2002	1284
Normalization of fasting hyperglycaemia by exogeno...	1993	1076
Switching from Insulin to Oral Sulfonylureas in Pa...	2006	971
Inhibition of gastric inhibitory polypeptide signa...	2002	937
Improvement of Insulin Sensitivity after Lean Dono...	2017	936

Publications

1.
The Physiology of Glucagon-like Peptide 1
Year: 2007Citations: 3107DOI: 10.1152/physrev.00034.2006
2.
Type 2 diabetes mellitus
Year: 2015Citations: 2351DOI: 10.1038/nrdp.2015.19
3.
Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.
Year: 1993Citations: 1609DOI: 10.1172/jci116186
4.
Glucagon-like peptide 1 (GLP-1)
Year: 2019Citations: 1549DOI: 10.1016/j.molmet.2019.09.010
5.
Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.
Year: 1998Citations: 1372DOI: 10.1172/jci990
6.
Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study
Year: 2002Citations: 1284DOI: 10.1016/s0140-6736(02)07952-7
7.
Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in Type 2 (non-insulin-dependent) diabetic patients
Year: 1993Citations: 1076DOI: 10.1007/bf00401145
8.
Switching from Insulin to Oral Sulfonylureas in Patients with Diabetes Due to Kir6.2 Mutations
Year: 2006Citations: 971DOI: 10.1056/nejmoa061759
9.
Inhibition of gastric inhibitory polypeptide signaling prevents obesity
Year: 2002Citations: 937DOI: 10.1038/nm727
10.
Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition
Year: 2017Citations: 936DOI: 10.1016/j.cmet.2017.09.008

About Jens J. Holst

Jens J. Holst is a researcher with 2699 publications and 157627 citations. They are affiliated with Novo Nordisk Foundation. Their research focuses on . With an h-index of 192, they are among the top researchers in their field.

Citation Distribution

Distribution of citations across publications

Research Smarter

AnswerThis uses AI to help you search, understand, and cite research from Jens J. Holst and 250M+ other papers.

AI-powered research assistance
Automatic citations and references
Advanced academic writing tools

Research Area Breakdown

Publication Types

Publication type data not available

Impact Metrics Over Time

Citations per publication by year